Christopher McQuinn, MD
Vascular Surgery · Raleigh, NCNPI 1194168906
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.8%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 51.0% of the total. 2025 is the largest year on record at $24,104, more than ten times the $11 reported in 2019. Among vascular surgery clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $313.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$39K
- Bolton Medical Inc$25K
- W. L. Gore & Associates, Inc.$8K
- Penumbra, Inc.$2K
- Silk Road Medical, Inc.$979
- Terumo Medical Corporation$515
- plus $719 from 16 others
Across 2 payments — averaging $3489.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bolton Medical Inc$7K
What the payments were for
- Consulting fees$36,62548%
- Speaking & faculty fees$6,8009%
- Grants$12,50016%
- Travel & lodging$11,78615%
- Food & beverage$8,85212%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 52 | $39,084 |
| Bolton Medical Inc | 79 | $25,414 |
| W. L. Gore & Associates, Inc. | 42 | $7,713 |
| Penumbra, Inc. | 20 | $2,139 |
| Silk Road Medical, Inc. | 5 | $979 |
| Terumo Medical Corporation | 23 | $515 |
| Boston Scientific | 3 | $119 |
| Lemaitre Vascular, Inc. | 1 | $104 |
| Endologix LLC | 1 | $96 |
| Johnson & Johnson | 1 | $60 |
| Pfizer | 3 | $56 |
| Imperative Care, Inc | 1 | $50 |
| Abbott | 2 | $48 |
| Sanara Medtech Inc. | 3 | $39 |
| Polynovo North America LLC | 1 | $25 |
| Cardiovascular Systems Inc. | 1 | $22 |
| Philips North America LLC | 1 | $22 |
| Baxter Healthcare | 1 | $19 |
| Avita Medical Americas, LLC | 1 | $18 |
| Davol Inc. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $14 |
| Getinge USA Sales, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TREO ABDOMINAL STENT-GRAFT SYSTEM$21,217
- ENDURANT IIS$9,486
- Endurant$7,630
- Valiant Navion$5,000
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$4,810
- GORE TAG Thoracic Branch Endoprosthesis$3,684
- IN.PACT Admiral$2,000
- HawkOne$2,000
- Protege RX$2,000
- EVERFLEX PROTEGE EVERFLEX$2,000
- AMPLATZ GOOSE NECK$2,000
- Admiral Xtreme$2,000
- Nitrex$2,000
- TrailBlazer$2,000
- Indigo System$1,458
- Grafts$1,095
- ENROUTE Transcarotid Neuroprotection System$821
- ENROUTE Transcarotid Stent$821
- GORE TAG Thoracic Endoprosthesis$816
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$389
How this compares
$76,563 in reported general payments places this provider in the 90th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 52 | $29,306 |
| EliquisApixaban | 28 | $14,135 |
| Cilostazol | 35 | $1,083 |
| ClopidogrelClopidogrel Bisulfate | 68 | $757 |
| Gabapentin | 65 | $693 |
| Atorvastatin Calcium | 30 | $251 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $60 | $29,30652 claims |
| PfizerEliquis | $56 | $14,13528 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 119 vascular surgery providers in North Carolina.
Other vascular surgery in Raleigh
- Robert MendesRaleigh$408K
- Ellen DillavouRaleigh$284K
- Joseph SalfityRaleigh$13K
- Jason KimRaleigh$8K
- Kirk CharlesRaleigh$8K
- Liliana NanezRaleigh$7K
- Heather WaldropRaleigh$5K
- Jacek PaszkowiakRaleigh$4K
- James FogartieRaleigh$3K
- Frank ArkoCharlotte$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.